Composites consisting of calcium phosphate cements and mesoporous bioactive glasses as a 3D plottable drug delivery system
Source abstract
Abstract
Calcium phosphate cements (CPC) and mesoporous bioactive glasses (MBG) are two well studied biomaterial groups widely under investigation on their applicability to treat bone defects in orthopaedics and maxillofacial surgery. Recently the extrusion properties of CPC-MBG composites using a pasty CPC based on a hydrophobic carrier-liquid were studied in our group demonstrating that such composites are suitable for low temperature 3D plotting. Based on this work, we show in this study that by variation of the MBG content in the composite the degradation of the final scaffolds can be influenced. Furthermore, by modifying the cement phase and/or the MBG with therapeutically active ions like strontium, the released ion concentration can be varied over a wide range. In a second step the MBG was functionalized exploiting the high specific surface area of the glass as a carrier system for proteins like lysozyme or grow factors. We developed a protocol that allows the incorporation of protein-laden MBG in CPC pastes without impairing the extrudability of the CPC-MBG composites. Additionally, we found that released proteins from pure MBG or 3D plotted composite-scaffolds maintained their biological activity. Therefore, the combination of CPC and MBG allows the creation of a highly flexible composite system making it a promising candidate for bone tissue engineering. STATEMENT OF SIGNIFICANCE: Calcium phosphate cements and mesoporous bioactive glasses are two promising degradable biomaterials for the regenerative treatment of bone defects. The combination of both materials to a 3D printable composite enables the creation of implants with patient specific geometry. By varying the composition of the composite, the degradation behaviour can be influenced and especially the release of therapeutically active ions is tailorable over a wide range. We demonstrated this for strontium, as it has been shown to stimulate bone formation. Moreover, the bioactive glass can be used as a carrier system for drugs or growth factors and we show the successful combination of such functionalised glass particles and a cement paste without affecting the printability.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Calcium Carbonate Crystallization and Inhibition
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Calcium phosphate ceramics in bone tissue engineering: a review of properties and their influence on cell behavior10.1016/j.actbio.2013.06.014 ↗
2. Calcium Orthophosphates as Bioceramics: state of the Art10.3390/jfb1010022 ↗
3. Calcium phosphates in biomedical applications: materials for the future?10.1016/j.mattod.2015.10.008 ↗
4. Calcium Phosphate Cement: review of Mechanical and Biological Properties10.1111/j.1532-849X.2006.00129.x ↗
5. Self-setting calcium orthophosphate formulations: cements, concretes, pastes and putties10.5923/j.ijmc.20110101.01 ↗
6. Calcium phosphate cements for bone engineering and their biological properties10.1038/boneres.2017.56 ↗
7. Self-hardening calcium deficient hydroxyapatite/gelatine foams for bone regeneration10.1007/s10856-009-3918-7 ↗
8. Robocasting of biomimetic hydroxyapatite scaffolds using self-setting inks10.1039/C4TB00438H ↗
9. Osteoinduction by Foamed and 3D-Printed Calcium Phosphate Scaffolds: effect of Nanostructure and Pore Architecture10.1021/acsami.7b14175 ↗
10. Injectability of calcium phosphate pastes10.1016/j.biomaterials.2004.05.010 ↗
11. Properties of injectable ready-to-use calcium phosphate cement based on water-immiscible liquid10.1016/j.actbio.2012.12.017 ↗
12. Fabrication of porous scaffolds by three-dimensional plotting of a pasty calcium phosphate bone cement under mild conditions10.1002/term.1563 ↗
13. Design and fabrication of complex scaffolds for bone defect healing: combined 3d plotting of a calcium phosphate cement and a growth factor-loaded hydrogel10.1007/s10439-016-1685-4 ↗
14. 3D printing of bone grafts for cleft alveolar osteoplasty – in vivo evaluation in a preclinical model10.3389/fbioe.2020.00217 ↗
15. Bonding mechanisms at the interface of ceramic prosthetic materials10.1002/jbm.820050611 ↗
16. Bioactive Glasses: frontiers and Challenges10.3389/fbioe.2015.00194 ↗
17. Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application10.1098/rsfs.2011.0121 ↗
18. A Guided Walk through the World of Mesoporous Bioactive Glasses (MBGs): fundamentals10.3390/nano10122571 ↗
19. Fabrication of mesoporous calcium silicate/calcium phosphate cement scaffolds with high mechanical strength by freeform fabrication system with micro-droplet jetting10.1007/s10853-015-9244-1 ↗
20. RhBMP-2 loaded 3D-printed mesoporous silica/calcium phosphate cement porous scaffolds with enhanced vascularization and osteogenesis properties
21. Calcium phosphate bone cement/mesoporous bioactive glass composites for controlled growth factor delivery10.1039/C6BM00903D ↗
22. Effects of a pasty bone cement containing brain-derived neurotrophic factor-functionalized mesoporous bioactive glass particles on metaphyseal healing in a new murine osteoporotic fracture model10.3390/ijms19113531 ↗
23. Development and characterization of composites consisting of calcium phosphate cements and mesoporous bioactive glass for extrusion-based fabrication10.3390/ma12122022 ↗
24. Strontium-modified premixed calcium phosphate cements for the therapy of osteoporotic bone defects10.1016/j.actbio.2017.10.036 ↗
25. Incorporation of silicon into strontium modified calcium phosphate bone cements promotes osteoclastogenesis of human peripheral mononuclear blood cells10.1088/1748-605X/aaf701 ↗
26. Highly Ordered Mesoporous Bioactive Glasses with Superior In Vitro Bone-Forming Bioactivities10.1002/anie.200460598 ↗
27. Trabecular bone response to injectable calcium phosphate (Ca-P) cement10.1002/jbm.10029 ↗
28. Injectable bone cements for use in vertebroplasty and kyphoplasty: state-of-the-art review10.1002/jbm.b.30398 ↗
29. Understanding of dopant-induced osteogenesis and angiogenesis in calcium phosphate ceramics10.1016/j.tibtech.2013.06.005 ↗
30. A novel and easy-to-prepare strontium(II) modified calcium phosphate bone cement with enhanced mechanical properties10.1016/j.actbio.2013.03.014 ↗
31. Synthesis and characterization of mesoporous CaO–MO–SiO2–P2O5 (M = Mg, Zn, Cu) bioactive glasses/composites10.1039/b805114c ↗
32. Substitutions of cerium, gallium and zinc in ordered mesoporous bioactive glasses10.1016/j.actbio.2011.05.033 ↗
33. Tailorable zinc-substituted mesoporous bioactive glass/alginate-methylcellulose composite bioinks10.3390/ma14051225 ↗
34. Induction of VEGF secretion from bone marrow stromal cell line (ST-2) by the dissolution products of mesoporous silica glass particles containing CuO and SrO10.1016/j.jnoncrysol.2018.07.073 ↗
35. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro10.1016/j.bone.2007.08.043 ↗
36. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro10.1016/8756-3282(96)00080-4 ↗
37. In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells10.1002/jor.21127 ↗
38. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins10.1359/jbmr.070321 ↗
39. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation10.1016/S0014-2999(02)02040-X ↗
40. S 12911-2 Inhibits Osteoclastic Bone Resorption In Vitro10.1359/jbmr.2003.18.6.1082 ↗
41. Mesoporous Materials for Drug Delivery10.1002/anie.200604488 ↗
42. Preparation of hierarchically mesoporous bioactive glass and immobilization of lysozyme10.1007/s10971-018-4753-4 ↗
43. Silica nanofibers as a new drug delivery system: a study of the protein–silica interactions10.1039/C7TB00332C ↗
44. Bioactive mesopore-glass microspheres with controllable protein-delivery properties by biomimetic surface modification10.1002/jbm.a.32873 ↗
45. Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system10.1016/j.jconrel.2005.11.002 ↗
46. Anti-osteoporotic drug release from ordered mesoporous bioceramics: experiments and modeling10.1208/s12249-011-9688-9 ↗
47. Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability10.1016/j.actbio.2011.03.009 ↗
48. Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineering10.1016/j.micromeso.2007.10.029 ↗
49. Modifications of a calcium phosphate cement with biomolecules-Influence on nanostructure, material, and biological properties10.1002/jbm.a.32920 ↗
50. Systems for therapeutic angiogenesis in tissue engineering10.1007/PL00007070 ↗
51. Vascular endothelial growth factors10.1016/j.jacc.2006.09.053 ↗
52. Central growth factor loaded depots in bone tissue engineering scaffolds for enhanced cell attraction
53. Release from alginate enhances the biological activity of vascular endothelial growth factor10.1163/156856298X00389 ↗